Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines. Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.
Find more information at www.vaxess.com. Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.
Find more information at www.vaxess.com. Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.
Find more information at www.vaxess.com.
Market
Vaccines and Therapeutics
Location
Cambridge,
MA,
US
Coinvestors
RA Capital Management, Engine Ventures, GHIC, Mission Bio Capital